{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:23:21Z","timestamp":1790166201905,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bcmd.2014.07.002","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T12:01:15Z","timestamp":1406721675000},"page":"194-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["BMI1 gene expression in myeloid leukemias and its impact on prognosis"],"prefix":"10.1016","volume":"53","author":[{"given":"Niveen S.","family":"Saudy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman M.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Azmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas F.","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Eneen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Abdul Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2014.07.002_bb0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/leu.2012.368","article-title":"Polycomb-group proteins in hematopoietic stem cell regulation and hematopoietic neoplasms","volume":"27","author":"Radulovi\u0107","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1532\/IJH97.05013","article-title":"BMI-1 is highly expressed in M0-subtype acute myeloid leukemia","volume":"82","author":"Sawa","year":"2005","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bcmd.2014.07.002_bb0015","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.leu.2404623","article-title":"Expression of polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia","volume":"21","author":"Chowdhury","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00277-008-0603-8","article-title":"BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia","volume":"88","author":"Bhattacharyya","year":"2009","journal-title":"Ann. Hematol."},{"issue":"12","key":"10.1016\/j.bcmd.2014.07.002_bb0130","first-page":"574","article-title":"Expression and clinical significance of Bmi-1 protein in bladder cancer","volume":"27","author":"Qin","year":"2008","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0030","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MOH.0b013e328338c439","article-title":"Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells","volume":"17","author":"Schuringa","year":"2010","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bcmd.2014.07.002_bb0035","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1182\/blood-2010-05-267096","article-title":"Polycomb proteins in hematologic malignancies","volume":"116","author":"Perez","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2003.07.009","article-title":"The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a\/p14ARF proteins","volume":"203","author":"Kim","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcmd.2014.07.002_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2011.11.012","article-title":"Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome","volume":"317","author":"Xu","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcmd.2014.07.002_bb0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/16476","article-title":"The oncogene and polycombgroup gene bmi-1 regulates cell proliferation and senescence through the ink4a locus","volume":"397","author":"Jacobs","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.leu.2403187","article-title":"Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML","volume":"18","author":"Schoch","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1097-2765(01)00346-X","article-title":"Linking the Rb and polycomb pathways","volume":"8","author":"Dahiya","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0065","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood.V97.12.3896","article-title":"Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma","volume":"97","author":"van Kemenade","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood-2005-06-2393","article-title":"Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis","volume":"107","author":"Mihara","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0135","first-page":"92","article-title":"Coexpression of BMI-1 and interleukin-3 receptor alpha chain (CD123) correlate with poor prognosis acute myeloid leukemia. AcademyPublish.org","volume":"2","author":"Dybko","year":"2013","journal-title":"J. Eng. Technol."},{"key":"10.1016\/j.bcmd.2014.07.002_bb0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood-2006-12-065599","article-title":"The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia","volume":"110","author":"Mohty","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0085","first-page":"2409","article-title":"BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas","volume":"61","author":"Be\u00e0","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2014.07.002_bb0090","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0092-8674(91)90382-9","article-title":"Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging","volume":"65","author":"van Lohuizen","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0095","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1182\/blood-2008-06-162388","article-title":"European LeukemiaNet criteria for failure or sub-optimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor","volume":"112","author":"Marin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/10428190601186002","article-title":"Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation","volume":"48","author":"Merkerova","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0105","doi-asserted-by":"crossref","first-page":"e55820","DOI":"10.1371\/journal.pone.0055820","article-title":"Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma","volume":"8","author":"Proctor","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.bcmd.2014.07.002_bb0110","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0115","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","article-title":"BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34 cells","volume":"116","author":"Rizo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0120","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1182\/blood-2011-06-359232","article-title":"Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells","volume":"119","author":"Sengupta","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.07.002_bb0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20111709","article-title":"Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes","volume":"209","author":"Oguro","year":"2012","journal-title":"J. Exp. Med."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:31:04Z","timestamp":1761049864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979614000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1079979614000692"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.07.002","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BMI1 gene expression in myeloid leukemias and its impact on prognosis","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}